JOHNSON & JOHNSON Capital Expenditures 2007-2026 | JNJ
Beta
What is capital expenditures?
Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.
What is JOHNSON & JOHNSON's current capital expenditures?
JOHNSON & JOHNSON (JNJ) annual capital expenditures for 2025 was $4.83B, a 9.22% increase from 2024. JOHNSON & JOHNSON capital expenditures for the quarter ending March 29, 2026 was $1.05B.
What was JOHNSON & JOHNSON's capital expenditures in 2024?
JOHNSON & JOHNSON annual capital expenditures for 2024 was $4.42B, a 2.62% decline from 2023.
What was JOHNSON & JOHNSON's capital expenditures in 2023?
JOHNSON & JOHNSON annual capital expenditures for 2023 was $4.54B, a 24.40% increase from 2022.
What is JOHNSON & JOHNSON's 4-year capital expenditures CAGR?
JOHNSON & JOHNSON capital expenditures grew at a compound annual growth rate (CAGR) of 9.61% from FY2021 to FY2025, going from $3.35B to $4.83B over 4 years.
Capital Expenditures History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+6.7%
FY2019
$3.50B
→
FY2025
$4.83B
07081011121314161718192122232425
5 years selected
Capital Expenditures History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.83B | +9.2% | 10-K |
| FY2024 | $4.42B | -2.6% | 10-K |
| FY2023 | $4.54B | +24.4% | 10-K |
| FY2022 | $3.65B | +9.1% | 10-K |
| FY2021 | $3.35B | -4.3% | 10-K |
| FY2019 | $3.50B | -4.7% | 10-K |
| FY2018 | $3.67B | +11.9% | 10-K |
| FY2017 | $3.28B | -5.3% | 10-K |
| FY2016 | $3.46B | -6.8% | 10-K |
| FY2014 | $3.71B | +3.3% | 10-K |
| FY2013 | $3.60B | +22.5% | 10-K |
| FY2012 | $2.93B | +23.1% | 10-K |
| FY2011 | $2.38B | +0.8% | 10-K |
| FY2010 | $2.37B | -22.9% | 10-K |
| FY2008 | $3.07B | +4.2% | 10-K |
| FY2007 | $2.94B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →